Cardlytics Announces Third Quarter 2018 Financial Results

Go back to Cardlytics Announces Third Quarter 2018 Financial Results

Cardlytics (CDLX) PT Lowered to $26 at KeyBanc Following 3Q

November 14, 2018 8:22 AM EST

KeyBanc analyst Andy Hargreaves lowered the price target on Cardlytics (NASDAQ: CDLX) to $26.00 (from $28.00) while maintaining a Overweight rating following the company's 3Q. Cardlytics reported mixed 3Q18 results as revenue missed due to advertiser churn, but cost management preserved upside in profitability... More

Cardlytics (CDLX) Reports Q3 Loss of $0.15

November 13, 2018 4:16 PM EST

Cardlytics (NASDAQ: CDLX) reported Q3 EPS of ($0.15), versus $0.20 reported last year. Revenue for the quarter came in at $34.6 million versus the consensus estimate of $37.58 million.

Total revenue was $34.6 million, an increase of 10% year-over-year, compared to $31.4 million in the third quarter of 2017.Cardlytics Direct revenue was $34.4 million, an increase of 14%, compared to $30.2 million in the third... More